Follicle-Stimulating Hormone Positively Associates with Metabolic Factors in Perimenopausal Women.

ABSTRACT:

Objective

Menopause is associated with the increased risk of metabolic syndrome (MetS) and cardiovascular (CV) disease. Most studies have focused the postmenopausal women and the relationships among estrogen, androgen, and Mets risk. The main aim of the study was to investigate the Mets risk in perimenopausal women and whether the variation of FSH is associated with metabolic factors.

Methods

A single-center cross-sectional retrospective analysis including 154 premenopausal women and 124 perimenopausal women was performed.

Results

The prevalence of Mets in the perimenopausal group was much higher than the premenopausal group (49.19% vs. 35.71%, p = 0.023). The prevalence of central obesity and NAFLD also increased in the perimenopausal group than in the premeno

SUBMITTER: Zhang C 

PROVIDER: S-EPMC7676929 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature